EFV
Eva Fortea Verdejo Wells Fargo Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
24
Avg Return
Past Year
Past Year
29%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
60.6%
Neutral
36.4%
Negative
3%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Initiated
| $40 |
42%
upside
| 1 | -4.3% |
0
%
| 2 Mar ‘26 2 days ago |
|
|
|
Overweight
Maintained
| $15 |
48%
upside
| 3 | +14% |
0
%
| 27 Feb ‘26 5 days ago |
|
|
|
Overweight
Maintained
| $144 |
42%
upside
| 2 | +77% |
0
%
| 26 Feb ‘26 6 days ago |
|
|
|
Overweight
Maintained
| $53 |
12%
upside
| 3 | +21% |
0
%
| 25 Feb ‘26 7 days ago |
|
|
|
Equal-Weight
Downgraded
| $23 |
1%
upside
| 4 | +40% |
0
%
| 12 Feb ‘26 20 days ago |
|
|
|
Equal-Weight
Maintained
| $35 |
16%
downside
| 1 | – |
–
| 11 Feb ‘26 21 days ago |
|
|
|
Overweight
Upgraded
| $33 |
31%
upside
| 4 | +1.2% |
0
%
| 12 Dec ‘25 2 months ago |
|
|
|
Equal-Weight
Maintained
| $11 |
41%
downside
| 3 | -33% |
0
%
| 11 Nov ‘25 3 months ago |
|
|
|
Overweight
Initiated
| $60 |
78%
upside
| 1 | +4.8% |
0
%
| 31 Oct ‘25 4 months ago |
|
|
|
Equal-Weight
Downgraded
| $97 | – | 4 | +40% |
0
%
| 30 Sep ‘25 5 months ago |
|
|
|
Equal-Weight
Maintained
| $11 | – | 5 | +5.7% |
0
%
| 7 Aug ‘25 6 months ago |
|
|
|
Overweight
Maintained
| $27 |
112%
upside
| 1 | +70% |
0
%
| 7 Aug ‘25 6 months ago |
|
|
|
Overweight
Initiated
| $44 |
27%
upside
| 1 | +58% |
0
%
| 26 Jun ‘25 8 months ago |
|